Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients.
Future Microbiol. 2022 Mar;17:339-350. doi: 10.2217/fmb-2022-0014. Epub 2022 Feb 9.
Future Microbiol. 2022.
PMID: 35135310
Free PMC article.